药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Racepinephrine
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Racepinephrine.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Doxofylline
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Doxofylline.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Vilanterol
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Vilanterol.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Olodaterol
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Olodaterol.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Hexoprenaline
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Hexoprenaline.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Protokylol
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Protokylol.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Celiprolol
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Celiprolol.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Hyaluronidase (human recombinant)
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Corticorelin ovine triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be increased when combined with Prednisolone acetate.
Methyl nonanoate
Satralizumab
The serum concentration of Elexacaftor can be decreased when it is combined with Satralizumab.
Methyl nonanoate
Abametapir
The serum concentration of Elexacaftor can be increased when it is combined with Abametapir.
Methyl nonanoate
Cenobamate
The serum concentration of Elexacaftor can be decreased when it is combined with Cenobamate.
Methyl nonanoate
Berotralstat
The serum concentration of Elexacaftor can be increased when it is combined with Berotralstat.
Methyl nonanoate
Fosnetupitant
The serum concentration of Elexacaftor can be increased when it is combined with Fosnetupitant.
Methyl nonanoate
Benidipine
The serum concentration of Elexacaftor can be increased when it is combined with Benidipine.
Methyl nonanoate
Barnidipine
The serum concentration of Elexacaftor can be increased when it is combined with Barnidipine.
Methyl nonanoate
Indalpine
The serum concentration of Elexacaftor can be increased when it is combined with Indalpine.
Methyl nonanoate
Luliconazole
The serum concentration of Elexacaftor can be increased when it is combined with Luliconazole.